Annual Current Liabilities
$7.46 M
+$5.66 M+314.17%
July 31, 2024
Summary
- As of February 26, 2025, BCTX annual total current liabilities is $7.46 million, with the most recent change of +$5.66 million (+314.17%) on July 31, 2024.
- During the last 3 years, BCTX annual current liabilities has risen by +$6.90 million (+1240.01%).
- BCTX annual current liabilities is now at all-time high.
Performance
BCTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.99 M
-$2.47 M-33.14%
October 31, 2024
Summary
- As of February 26, 2025, BCTX quarterly total current liabilities is $4.99 million, with the most recent change of -$2.47 million (-33.14%) on October 31, 2024.
- Over the past year, BCTX quarterly current liabilities has stayed the same.
- BCTX quarterly current liabilities is now -33.14% below its all-time high of $7.46 million, reached on July 31, 2024.
Performance
BCTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BCTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +314.2% | 0.0% |
| 3 y3 years | +1240.0% | 0.0% |
| 5 y5 years | +558.4% | 0.0% |
BCTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1240.0% | -33.1% | +1261.9% |
| 5 y | 5-year | at high | +1240.0% | -33.1% | +2836.2% |
| alltime | all time | at high | >+9999.0% | -33.1% | >+9999.0% |
BriaCell Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $4.99 M(-33.1%) |
| Jul 2024 | $7.46 M(+314.2%) | $7.46 M(+10.4%) |
| Apr 2024 | - | $6.76 M(+72.2%) |
| Jan 2024 | - | $3.92 M(+275.0%) |
| Oct 2023 | - | $1.05 M(-41.9%) |
| Jul 2023 | $1.80 M(+91.4%) | $1.80 M(+30.3%) |
| Apr 2023 | - | $1.38 M(+106.3%) |
| Jan 2023 | - | $670.40 K(-31.2%) |
| Oct 2022 | - | $974.00 K(+3.5%) |
| Jul 2022 | $941.10 K(+69.0%) | $941.10 K(+156.9%) |
| Apr 2022 | - | $366.30 K(-39.5%) |
| Jan 2022 | - | $605.10 K(+40.3%) |
| Oct 2021 | - | $431.40 K(-22.5%) |
| Jul 2021 | $556.80 K(-86.0%) | $556.80 K(+227.7%) |
| Apr 2021 | - | $169.90 K(-95.7%) |
| Jan 2021 | - | $3.94 M(+7.1%) |
| Oct 2020 | - | $3.68 M(-7.2%) |
| Jul 2020 | $3.96 M(+249.8%) | $3.96 M(+24.0%) |
| Apr 2020 | - | $3.20 M(+16.6%) |
| Jan 2020 | - | $2.74 M(+112.0%) |
| Oct 2019 | - | $1.29 M(+14.1%) |
| Jul 2019 | $1.13 M(-15.4%) | $1.13 M(+104.1%) |
| Apr 2019 | - | $555.40 K(-64.0%) |
| Jan 2019 | - | $1.54 M(+47.6%) |
| Oct 2018 | - | $1.04 M(-22.0%) |
| Jul 2018 | $1.34 M(+51.2%) | $1.34 M(-1.5%) |
| Apr 2018 | - | $1.36 M(+315.9%) |
| Jan 2018 | - | $327.10 K(-0.7%) |
| Oct 2017 | - | $329.30 K(-62.8%) |
| Jul 2017 | $885.90 K(+1722.8%) | $885.90 K(+6319.6%) |
| Apr 2017 | - | $13.80 K(+84.0%) |
| Jan 2017 | - | $7500.00(-77.2%) |
| Oct 2016 | - | $32.90 K(-32.3%) |
| Jul 2016 | $48.60 K(-58.5%) | $48.60 K(-37.1%) |
| Apr 2016 | - | $77.30 K(-4.3%) |
| Jan 2016 | - | $80.80 K(-23.2%) |
| Oct 2015 | - | $105.20 K(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2015 | $117.20 K(+368.8%) | $117.20 K(-3.6%) |
| Apr 2015 | - | $121.60 K(+2.7%) |
| Jan 2015 | - | $118.40 K(-94.3%) |
| Oct 2014 | - | $2.09 M(+8240.8%) |
| Jul 2014 | $25.00 K(-66.4%) | $25.00 K(-68.5%) |
| Apr 2014 | - | $79.40 K(+0.3%) |
| Jan 2014 | - | $79.20 K(+7.0%) |
| Oct 2013 | - | $74.00 K(-0.7%) |
| Jul 2013 | $74.50 K(-73.8%) | $74.50 K(+106.9%) |
| Apr 2013 | - | $36.00 K(+25.4%) |
| Jan 2013 | - | $28.70 K(-75.3%) |
| Oct 2012 | - | $116.00 K(-59.1%) |
| Jul 2012 | $283.90 K(-60.4%) | $283.90 K(+236.0%) |
| Apr 2012 | - | $84.50 K(+134.1%) |
| Jan 2012 | - | $36.10 K(-89.9%) |
| Oct 2011 | - | $357.20 K(-50.2%) |
| Jul 2011 | $716.70 K(+2354.5%) | $716.70 K(+863.3%) |
| Apr 2011 | - | $74.40 K(-12.9%) |
| Jan 2011 | - | $85.40 K(-6.3%) |
| Oct 2010 | - | $91.10 K(+212.0%) |
| Jul 2010 | $29.20 K(-54.5%) | $29.20 K(-27.7%) |
| Apr 2010 | - | $40.40 K(+329.8%) |
| Jan 2010 | - | $9400.00(-66.8%) |
| Oct 2009 | - | $28.30 K(-55.9%) |
| Jul 2009 | $64.20 K(+311.5%) | $64.20 K(+1046.4%) |
| Apr 2009 | - | $5600.00(-50.9%) |
| Jan 2009 | - | $11.40 K(+293.1%) |
| Oct 2008 | - | $2900.00(-81.4%) |
| Jul 2008 | $15.60 K(+62.5%) | $15.60 K(+437.9%) |
| Apr 2008 | - | $2900.00(-39.6%) |
| Jan 2008 | - | $4800.00(-63.4%) |
| Oct 2007 | - | $13.10 K(+36.5%) |
| Jul 2007 | $9600.00(-41.8%) | $9600.00(+380.0%) |
| Apr 2007 | - | $2000.00(+566.7%) |
| Jan 2007 | - | $300.00(-97.2%) |
| Oct 2006 | - | $10.90 K |
| Jul 2006 | $16.50 K | - |
FAQ
- What is BriaCell Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual current liabilities year-on-year change?
- What is BriaCell Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly current liabilities year-on-year change?
What is BriaCell Therapeutics annual total current liabilities?
The current annual current liabilities of BCTX is $7.46 M
What is the all time high annual current liabilities for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual total current liabilities is $7.46 M
What is BriaCell Therapeutics annual current liabilities year-on-year change?
Over the past year, BCTX annual total current liabilities has changed by +$5.66 M (+314.17%)
What is BriaCell Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of BCTX is $4.99 M
What is the all time high quarterly current liabilities for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly total current liabilities is $7.46 M
What is BriaCell Therapeutics quarterly current liabilities year-on-year change?
Over the past year, BCTX quarterly total current liabilities has changed by $0.00 (0.00%)